VANCOUVER, Jan. 21, 2019 /CNW/ - INVICTUS MD
STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX:
IVITF; FRA: 8IS1) is pleased to announce that the
Company's wholly-owned subsidiary 0989561
B.C. Ltd. ("Canandia") has received a sales license for its
Delta location (the "Delta Facility") from Health Canada effective
January 18, 2019, pursuant to the
Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The
Delta Facility includes a cultivation, production and research
facility, designed to highlight our capabilities as producers and
breeders of superior cannabis strains.
Canandia's second asset is located in Mission (the "Mission
Location"), British Columbia. The
Mission Location includes 32 acres of buildable land, expandable up
to 1 million square feet of production capacity under one Cannabis
Act and Cannabis Regulations license. The Mission Location taps
into wholesale energy costs with 38 MG Watt service at the property
line, and boasts access to underground aquifers, making it a
strategically attractive and cost competitive addition to Invictus'
current cultivation footprint once developed and commissioned.
"We are thrilled to have achieved another major milestone with
our second sales license awarded by Health Canada," said George E.
Kveton, President and CEO of Invictus. "We have hit the ground
running in 2019, remaining laser focused on our objective to bring
new facilities online to cultivate unique strain varieties required
for our medical and adult use recreational product portfolio."
"I am exceptionally proud of our in-house Pharmaceutical
Regulatory Compliance Team today," said Alon Amit CEO of Canandia.
"Dr. Jaclyn Thompson, Quality
Assurance Supervisor, and Director of Research, and her team are
behind the issuance of our sales license months ahead of schedule,
and the smooth successful migration of our license issued under the
ACMPR to the Cannabis Act and its regulations. We look forward to
supplying the Canadian medical and recreational markets with our
menu of exotic cannabis strains"
Canandia represents the Company's third cultivation license and
second sales license issued by Health Canada under the Cannabis Act
and Cannabis Regulations. Invictus' production footprint includes
licensed cannabis operations in British
Columbia, Alberta and
Ontario.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
George E. Kveton
Chief Executive Officer and Director
Jessica Martin
Vice President, Public Relations and Regulatory Affairs
(833) 879-4363
About Invictus
Invictus is a global cannabis company offering a selection of
products under a wide range of brands. Our integrated sales
approach is defined by five pillars of distribution including
medical, adult-use, international, Licensed Producer to Licensed
Producer and retail stores.
Invictus has partnered with business leaders to convey our
corporate vision, including KISS music legend and business mogul
Gene Simmons as our Chief Evangelist
Officer. To meet growing demand, Invictus is expanding its
cultivation footprint, with three cannabis production facilities
licensed under the Cannabis Act and Cannabis Regulations in
Canada. To accommodate
international sales, Invictus' wholly-owned subsidiary, Acreage
Pharms Ltd. ("Acreage Pharms"), has designed and is currently
building its Phase 3 purpose-built cultivation facility to be
European Union Good Manufacturing Practices ("EU-GMP") compliant.
The Company is targeting up to 50 percent of production to medical
cannabis. To ensure consistency in quality and supply, Invictus
maintains all aspects of the growing process through its
subsidiary, Future Harvest Development Ltd. ("Future Harvest"), a
high-quality fertilizer and nutrients manufacturer. Invictus drives
sustainable long-term shareholder value through a diversified
product portfolio with over 70 Health Canada approved strains and a
multifaceted distribution strategy including medical, adult-use,
international, Licensed Producer to Licensed Producer and retail
stores. For more information visit www.invictus-md.com.
Neither the TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/invictus-canandia-awarded-sales-license-300781514.html
SOURCE Invictus MD Strategies
